Dapagliflozin-Sitagliptin in T2D: Moving Beyond HbA1c Towards a Broader Orbit of Care Written By Dr. Sudhir Bhandari6 Nov 2026 11:00 AM ISTType 2 diabetes (T2D) is increasingly recognised as a complex gluco-cardio-metabolic disease requiring more than glycaemic control alone. India has...
Metformin Effect on Biological Aging in Prediabetes: Latest 2026 Published Indian Research Written By Deeksha Bhandari23 Oct 2026 12:00 PM IST Metformin therapy significantly increased leukocyte telomere length, telomerase activity and SIRT1 gene expression in Indian adults with...
Metformin's Effect on Biological Ageing in Prediabetes: New 2026 Indian Study Written By Dr. Nandita Mohan16 Oct 2026 11:28 AM ISTMetformin increased leukocyte telomere length, telomerase activity and SIRT1 expression in Indian adults with prediabetes, suggesting potential...
Overcoming the Challenge of Maintaining Weight Reduction Written By Medical Dialogues Team7 Sept 2026 12:15 PM ISTIn this video, Dr Carel Le Roux, Clinician Scientist at University College Dublin, explains the challenge of maintaining weight reduction in people...
SURMOUNT -5 clinical trial data,Tirzepatide vs Semaglutide in obesity Written By Medical Dialogues Team27 Aug 2026 11:00 AM ISTSURMOUNT -5 clinical trial data, Tirzepatide vs Semaglutide in participants with obesity (BMI of 27 kilogram per square meter and above with a...
Key Takeaways on the Emerging Role of PPAR Agonists in MASLD/MASH: ADA 2026 Update Written By Dr. Kamal Kant Kohli20 Aug 2026 12:29 PM ISTAt the American Diabetes Association (ADA) Scientific Sessions 2026, Dr. Sonal Kumar, Hepatologist at Weill Cornell Medicine, New York, presented an...
From Monotherapy to Multi-Drug Regimens: Metformin's Role as the Therapeutic Backbone for Over Seven Decades Written By Dr. RITESH KU. AGRAWALA12 Jun 2026 10:41 AM ISTFor over seven decades, metformin has remained the cornerstone of T2DM management as monotherapy and in combination with other glucose-lowering...
Dapagliflozin and Metformin in T2D: Three Important Indian Evidences Revisited- Dr Semanti Chakraborty Written By Dr. Semanti Chakraborty10 Jun 2026 11:09 AM ISTIndia's Type 2 diabetes(T2D) prevalence is increasing, with over half of affected individuals remaining undiagnosed. More than 70% of Indian T2D...
Dapagliflozin & Sitagliptin Combination Emerges as Effective Strategy in T2DM Care Written By Dr Sunil Gupta4 May 2026 11:30 AM ISTIn this video, Dr Sunil Gupta, Diabetologist, CEO & MD, Sunil's Diabetes Care n' Research Centre Pvt. Ltd, Nagpur, discusses about the...
SURMOUNT-5 Trial: Tirzepatide vs Semaglutide in Obesity Management Written By MDTV Bureau20 April 2026 11:47 AM ISTThe SURMOUNT-5 trial evaluated the efficacy and safety of tirzepatide compared to semaglutide in adults with obesity or overweight with at least one...
USV Launches USEMA - DCGI-Approved Injectable Semaglutide for Type 2 Diabetes Written By Dr. Nandita Mohan21 March 2026 11:02 AM ISTUSV Private Limited, a leading name in diabetes care, has announced the launch of USEMA, its semaglutide injection, for the management of Type 2...
Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial Written By Deeksha Bhandari21 March 2026 9:00 AM ISTThe SURMOUNT-1 trial evaluated Tirzepatide a dual GIP/GLP1 agonist, in individuals with overweight (BMI more than or equal to 27 with a comorbidity)...
